StockWatch
·
Pharmaceuticals
Dividend22 Jun 2026, 07:50 pm

Biocon Ltd Recommends 10% Final Dividend for FY26

AI Summary

Biocon Ltd has announced its Board of Directors has recommended a final dividend of 10%, or ₹0.50 per equity share, for the Financial Year ended March 31, 2026. This dividend is subject to shareholder approval at the 48th Annual General Meeting scheduled for August 06, 2026. The record date for determining eligible shareholders is July 03, 2026. The company will deduct Tax at Source (TDS) on the dividend, with rates varying based on shareholder status and documentation. Shareholders are urged to update their PAN, address, and residential status with their Depository Participants or the company's RTA, KFin Technologies Limited, to ensure timely dividend credit.

Key Highlights

  • Biocon recommends a 10% final dividend for FY26.
  • Dividend subject to shareholder approval at AGM on August 06, 2026.
  • Record date for dividend eligibility is July 03, 2026.
  • TDS will be deducted on dividend payments.
  • Shareholders must update bank and KYC details to receive dividend.